{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:36:29Z","timestamp":1760160989021},"reference-count":36,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1700,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1465-3362.2010.00274.x","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T12:52:19Z","timestamp":1294231939000},"page":"613-620","source":"Crossref","is-referenced-by-count":20,"title":["Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients"],"prefix":"10.1111","volume":"30","author":[{"given":"BRIONY","family":"LARANCE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LOUISA","family":"DEGENHARDT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUSANNAH","family":"O'BRIEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NICK","family":"LINTZERIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ADAM","family":"WINSTOCK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RICHARD P.","family":"MATTICK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAMES","family":"BELL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROBERT","family":"ALI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,5]]},"reference":[{"issue":"2","key":"10.1111\/j.1465-3362.2010.00274.x-BIB1|cit1","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1360-0443.2003.00348.x","article-title":"Methadone-related and heroin-related deaths among opiate users: methadone helps save lives","volume":"98","author":"Mattick","year":"2003","journal-title":"Addiction"},{"issue":"2","key":"10.1111\/j.1465-3362.2010.00274.x-BIB3|cit3","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB4|cit4","volume-title":"Substitution maintenance therapy in the management of opioid dependence and HIV\/AIDS prevention","author":"World Health Organisation\/United Nations Office on Drugs and Crime\/Joint United Nations Programme on HIV\/AIDS","year":"2004"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB5|cit5","unstructured":"Winstock AR Bell J Clinical Guidelines: Assessing suitability for unsupervised medication doses in the treatment of opioid dependency The Royal Australasian College of Physicians, Adult Medicine Division 2006"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB6|cit6","volume-title":"National pharmacotherapy policy for people dependent on opioids","author":"Department of Health and Ageing","year":"2007"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1526-4637.2006.00255.x","article-title":"Mechanisms of prescription drug diversion among drug-involved club- and street-based populations","volume":"8","author":"Inciardi","year":"2007","journal-title":"Pain Med"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB8|cit8","volume-title":"The diversion and injection of the pharmaceutical opioids used in opioid substitution treatment: findings from the Australian post-marketing surveillance studies of buprenorphine-naloxone","author":"Larance","year":"2009"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.drugpo.2006.02.010","article-title":"The chronotope of the queue: methadone maintenance treatment and the production of time, space and subjects","volume":"17","author":"Fraser","year":"2006","journal-title":"Int J Drug Policy"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB10|cit10","volume-title":"Methadone maintenance treatment in New South Wales and Victoria: takeaways, diversion and other key issues","author":"Fraser","year":"2007"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/09687630600997527","article-title":"Valuing methadone takeaway doses: the contribution of service-user perspectives to policy and practice","volume":"14","author":"Treloar","year":"2007","journal-title":"Drugs Edu Prev Policy"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.324.7347.1183","article-title":"Increasing response rates to postal questionnaires: systematic review","volume":"324","author":"Edwards","year":"2002","journal-title":"BMJ"},{"issue":"3","key":"10.1111\/j.1465-3362.2010.00274.x-BIB13|cit13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.MR000008.pub4","article-title":"Methods to increase response to postal and electronic questionnaires","author":"Edwards","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB14|cit14","volume-title":"National Opioid Pharmacotherapy Statistics Annual Data collection: 2007 report","author":"Australian Institute of Health and Welfare","year":"2008"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.drugpo.2007.03.002","article-title":"Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia","volume":"19","author":"Winstock","year":"2008","journal-title":"Int J Drug Policy"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/10550880903028841","article-title":"What is diversion of supervised buprenorphine and how common is it?","volume":"28","author":"Winstock","year":"2009","journal-title":"J Addict Dis"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/713659430","article-title":"Patients in methadone maintenance treatment who inject methadone syrup: a preliminary study","volume":"19","author":"Robinson","year":"2000","journal-title":"Drug Alcohol Rev"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1360-0443.2000.95339310.x","article-title":"Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London","volume":"95","author":"Fountain","year":"2000","journal-title":"Addiction"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-6-51","article-title":"Difficulties associated with outpatient management of drug abusers by general practitioners with and without methadone patients in Switzerland","volume":"6","author":"Pelet","year":"2005","journal-title":"BMC Fam Pract"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1360-0443.1991.tb01779.x","article-title":"General practitioners' experiences of patients with drug and alcohol problems","volume":"86","author":"Roche","year":"1991","journal-title":"Br J Addict"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09595230601146645","article-title":"Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified","volume":"26","author":"Nielsen","year":"2007","journal-title":"Drug Alcohol Rev"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0376-8716(02)00312-5","article-title":"Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France","volume":"69","author":"Vidal-Trecan","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10550880802545036","article-title":"Methods and motivations for buprenorphine diversion from public opioid substitution treatment clinics","volume":"28","author":"Winstock","year":"2009","journal-title":"J Addict Dis"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1360-0443.2009.02774.x","article-title":"Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia","volume":"105","author":"Winstock","year":"2010","journal-title":"Addiction"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/0959523021000002679","article-title":"The general practitioner's role in AOD issues: overcoming individual, professional and systemic barriers","volume":"21","author":"Roche","year":"2002","journal-title":"Drug Alcohol Rev"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.pra.0000344917.43780.77","article-title":"Medication adherence: a review of the literature and implications for clinical practice","volume":"15","author":"Julius","year":"2009","journal-title":"J Psychiatr Pract"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2261-6-48","article-title":"Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease","volume":"6","author":"Ho","year":"2006","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.4088\/JCP.v67n0715","article-title":"A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia","volume":"67","author":"Ascher-Svanum","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpain.2008.10.009","article-title":"Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviours: a review of the evidence for an American Pain Society and American Academy of Pain Medicine Clinical Practice Guidelines","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviours in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1526-4637.2008.00491.x","article-title":"Reported lifetime aberrant drug-taking behaviours are predictive of current substance use and mental health problems in primary care patients","volume":"9","author":"Fleming","year":"2008","journal-title":"Pain Med"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1526-4637.2003.03018.x","article-title":"The need to identify predictors of aberrant drug-related behavior and addiction in patients being treated with opioids for pain","volume":"4","author":"Passik","year":"2003","journal-title":"Pain Med"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1526-4637.2009.00643.x","article-title":"Predictors of resolution of aberrant drug behavior in chronic pain patients treated in a structured opioid risk management program","volume":"10","author":"Meghani","year":"2009","journal-title":"Pain Med"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/01.ajp.0000161525.48245.aa","article-title":"Pain and aberrant drug-related behaviours in medically ill patients with and without histories of substance abuse","volume":"22","author":"Passik","year":"2006","journal-title":"Clin J Pain"},{"key":"10.1111\/j.1465-3362.2010.00274.x-BIB36|cit36","doi-asserted-by":"crossref","unstructured":"Aitken C Power R Dwyer R A very low response rate in an on-line survey of medical practitioners 2008 32 288 9","DOI":"10.1111\/j.1753-6405.2008.00232.x"}],"container-title":["Drug and Alcohol Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1465-3362.2010.00274.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1465-3362.2010.00274.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T08:38:37Z","timestamp":1625647117000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1465-3362.2010.00274.x"}},"subtitle":["Diversion\/injection among OST patients"],"short-title":[],"issued":{"date-parts":[[2011,1,5]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1465-3362.2010.00274.x","relation":{},"ISSN":["0959-5236"],"issn-type":[{"value":"0959-5236","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,5]]}}}